New patent for Astrazeneca Ab drug BYDUREON BCISE

Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appear…


New patent for Azurity drug FIRVANQ KIT

Annual Drug Patent Expirations for FIRVANQ+KIT Firvanq Kit is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Azurity drug FIRVANQ KIT appeared first on DrugPatent…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog